GB794798A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB794798A GB794798A GB27460/56A GB2746056A GB794798A GB 794798 A GB794798 A GB 794798A GB 27460/56 A GB27460/56 A GB 27460/56A GB 2746056 A GB2746056 A GB 2746056A GB 794798 A GB794798 A GB 794798A
- Authority
- GB
- United Kingdom
- Prior art keywords
- nonionic
- ammonium chloride
- sodium
- anionic
- cationic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A non-toxic effervescent pharmaceutical composition comprises a solid organic acid material such as tartaric, citric or succinic acid or their potassium or sodium acid salts and a material such as sodium bicarbonate or carbonate which reacts with the organic acid material on contact with moisture to form a gas and a surface-active agent. The surface-active agent may be cationic, anionic, or nonionic. In the first case it should preferably amount by weight to not more than 0.2 per cent of the composition; in the second, not more than 2 per cent; in the third, not more than 25 per cent. A mixture of cationic and nonionic or anionic and nonionic surface-active agents may be used. The pH of the dissolved composition in water should be from 2 to 10 and preferably 3 to 7. Specified surface-active agents are (a) cationic: coconut alkyl dimethylbenzyl ammonium chloride, cetyl trimethyl ammonium chloride, dodecyl dimethylallyl ammonium chloride, cetyl dimethylbenzyl ammonium chloride; (b) anionic: sodium lauryl sulphate, sodium hepta-decyl sulphate; (c) nonionic: the polyethylene glycol mono ester of ricinoleic acid or lauric acid, lauryl ether of polyalkoxyethanol, p-diisobutyl or p-triisopropyl phenoxypolyethoxyethanol having approximately 9 to 11 ethoxy groups. Therapeutic agents may be added for their specific effect: specified are propylparahydroxybenzoate, oxyquinoline sulphate, procaine hydrochloride, butethamine formate and hydrochloride, sulphacetamide, p-nitrosulphathiazole, bacitracin, aureomycin hydrochloride, potassium penicillin. Diluents such as starch and sucrose may be added and the composition may be tabletted. Many examples are given.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US794798XA | 1955-09-22 | 1955-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB794798A true GB794798A (en) | 1958-05-07 |
Family
ID=22150831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB27460/56A Expired GB794798A (en) | 1955-09-22 | 1956-09-07 | Pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB794798A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1179335B (en) * | 1959-03-13 | 1964-10-08 | Therapeutique Lab Franc De | Process to increase and extend the duration of action of drug dragees |
FR2035119A1 (en) * | 1969-03-20 | 1970-12-18 | Pfizer | |
CN105997924A (en) * | 2016-07-07 | 2016-10-12 | 驻马店华中正大有限公司 | Chlortetracycline hydrochloride effervescent tablets and preparation method thereof |
-
1956
- 1956-09-07 GB GB27460/56A patent/GB794798A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1179335B (en) * | 1959-03-13 | 1964-10-08 | Therapeutique Lab Franc De | Process to increase and extend the duration of action of drug dragees |
FR2035119A1 (en) * | 1969-03-20 | 1970-12-18 | Pfizer | |
CN105997924A (en) * | 2016-07-07 | 2016-10-12 | 驻马店华中正大有限公司 | Chlortetracycline hydrochloride effervescent tablets and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1441588A (en) | Rinse composition | |
JPS5017204B1 (en) | ||
US2854377A (en) | Effervescent compositions containing a surface active agent | |
GB847570A (en) | Shampoo compositions | |
GB794798A (en) | Pharmaceutical compositions | |
GB796633A (en) | Improvements in or relating to anti-freeze mixtures | |
GB1107441A (en) | New organic sulphated surfactants | |
GB882635A (en) | Cleaning composition | |
ES469632A1 (en) | Light duty non-irritating detergent compositions | |
GB1498835A (en) | Stabilisation of sodium metasilicate | |
ES451555A1 (en) | Shampoo composition | |
ES391536A1 (en) | Procedure for obtaining antibacterial compositions. (Machine-translation by Google Translate, not legally binding) | |
GB1131492A (en) | Detergent composition | |
GB874186A (en) | Shampoo compositions | |
GB1033907A (en) | Germicidal available iodine compositions and method for preparing the same | |
GB757155A (en) | Novel haemostatic compositions | |
GB797508A (en) | Improvements in or relating to therapeutically valuable cysteine compounds | |
GB868601A (en) | Tetracycline antibiotic compositions | |
GB770747A (en) | Improvements in or relating to detergent compositions | |
GB962585A (en) | Detergent compositions | |
ES230288A1 (en) | Improvements in cleaning compositions (Machine-translation by Google Translate, not legally binding) | |
GB678346A (en) | Improvements in the preparation of aqueous solutions of salts of p-amino-salicylic acid | |
GB937936A (en) | Quaternary ammonium bactericidal compositions | |
ES333245A1 (en) | A procedure for the preparation of a cleansing composition. (Machine-translation by Google Translate, not legally binding) | |
GB695797A (en) | Improvements in or relating to compositions for use in hair waving |